On Invalid Date, Zai Lab (NASDAQ: ZLAB) reported Q4 2023 earnings per share (EPS) of -$1.00, up 66.67% year over year. Total Zai Lab earnings for the quarter were -$95.43 million. In the same quarter last year, Zai Lab's earnings per share (EPS) was -$0.60.
As of Q2 2024, Zai Lab's earnings has grown year over year. Zai Lab's earnings in the past year totalled -$334.62 million.
What is ZLAB's earnings date?
Zai Lab's earnings date is Invalid Date. Add ZLAB to your watchlist to be reminded of ZLAB's next earnings announcement.
What was ZLAB's revenue last quarter?
On Invalid Date, Zai Lab (NASDAQ: ZLAB) reported Q4 2023 revenue of $65.83 million up 5.16% year over year. In the same quarter last year, Zai Lab's revenue was $62.60 million.
What was ZLAB's revenue growth in the past year?
As of Q2 2024, Zai Lab's revenue has grown 24.03% year over year. This is 125.48 percentage points lower than the US Biotechnology industry revenue growth rate of 149.51%. Zai Lab's revenue in the past year totalled $266.72 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.